CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
1-Year Return
42.86%
This Quarter Return
-2.44%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.01B
AUM Growth
-$402M
(-28%)
Cap. Flow
-$252M
Cap. Flow
% of AUM
-24.93%
Top 10 Holdings %
Top 10 Hldgs %
65.73%
Holding
37
New
7
Increased
7
Reduced
12
Closed
7
Top Buys
| 1 |
Globus Medical
GMED
|
$67.1M |
| 2 |
Tandem Diabetes Care
TNDM
|
$60.3M |
| 3 |
Align Technology
ALGN
|
$54.1M |
| 4 |
ARQL
Arqule Inc
ARQL
|
$28.4M |
| 5 |
Insulet
PODD
|
$25.7M |
Top Sells
| 1 |
Pacira BioSciences
PCRX
|
$122M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$76M |
| 3 |
UroGen Pharma
URGN
|
$51.5M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$51.1M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$44.5M |
Sector Composition
| 1 | Healthcare | 98.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Savara
SVRA
$643M
| $4.16M | 0.41% |
1,568,002
| – | – |
|
27
Sarepta Therapeutics
SRPT
$1.96B
| $904K | 0.09% |
+12,000
| New | +$904K |
|
28
Q32 Bio
QTTB
$20.4M
| $734K | 0.07% |
2,253
+800
| +55% | +$261K |
|
|
IMMU
29
DELISTED
Immunomedics Inc
IMMU
| $597K | 0.06% |
45,000
-100,000
| -69% | -$1.33M |
|
|
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $149K | 0.01% |
+20,000
| New | +$149K |
|
31
Corcept Therapeutics
CORT
$7.31B
| – | – |
-2,882,773
| Closed | -$32.1M |
|
32
Insmed
INSM
$30.7B
| – | – |
-1,711,150
| Closed | -$43.8M |
|
|
33
Pacira BioSciences
PCRX
$1.19B
| – | – |
-2,799,916
| Closed | -$122M |
|
|
34
UroGen Pharma
URGN
$873M
| – | – |
-1,433,774
| Closed | -$51.5M |
|
|
35
Vanda Pharmaceuticals
VNDA
$272M
| – | – |
-3,626,545
| Closed | -$51.1M |
|
|
ICPT
36
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-388,470
| Closed | -$30.9M |
|
|
AERI
37
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
-1,506,695
| Closed | -$44.5M |
|